Analysen von James Quigley
| 15.05.25 | Bayer Neutral | Goldman Sachs Group Inc. | |
| 01.05.25 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 28.04.25 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 25.04.25 | Sanofi Neutral | Goldman Sachs Group Inc. | |
| 25.04.25 | Bayer Neutral | Goldman Sachs Group Inc. | |
| 24.03.25 | Bayer Neutral | Goldman Sachs Group Inc. | |
| 21.03.25 | Sanofi Neutral | Goldman Sachs Group Inc. | |
| 11.03.25 | Bayer Neutral | Goldman Sachs Group Inc. | |
|
Werbung
|
|||
| 05.03.25 | Bayer Neutral | Goldman Sachs Group Inc. | |
| 11.02.25 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 06.02.25 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 31.01.25 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 30.01.25 | Sartorius vz. Neutral | Goldman Sachs Group Inc. | |
| 09.01.25 | Sartorius vz. Neutral | Goldman Sachs Group Inc. | |
| 09.01.25 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 22.11.24 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 21.11.24 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 13.11.24 | Bayer Neutral | Goldman Sachs Group Inc. | |
| 12.11.24 | Bayer Neutral | Goldman Sachs Group Inc. | |
| 31.10.24 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 29.10.24 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 17.10.24 | Sartorius vz. Neutral | Goldman Sachs Group Inc. | |
| 11.10.24 | Bayer Neutral | Goldman Sachs Group Inc. | |
| 11.10.24 | Bayer Neutral | Goldman Sachs Group Inc. | |
| 03.10.24 | Sartorius vz. Neutral | Goldman Sachs Group Inc. | |
| 02.10.24 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 18.09.24 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 10.09.24 | Bayer Neutral | Goldman Sachs Group Inc. | |
| 05.09.24 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 02.09.24 | Bayer Neutral | Goldman Sachs Group Inc. | |
| 07.08.24 | Bayer Neutral | Goldman Sachs Group Inc. | |
| 06.08.24 | Bayer Neutral | Goldman Sachs Group Inc. | |
| 05.08.24 | Bayer Neutral | Goldman Sachs Group Inc. | |
| 17.07.24 | Bayer Neutral | Goldman Sachs Group Inc. | |
| 08.07.24 | Bayer Neutral | Goldman Sachs Group Inc. | |
| 05.06.24 | Bayer Neutral | Goldman Sachs Group Inc. | |
| 30.05.24 | GSK Neutral | Goldman Sachs Group Inc. | |
| 30.05.24 | Bayer Neutral | Goldman Sachs Group Inc. | |
| 21.07.23 | Bayer Equal-weight | Morgan Stanley | |
| 06.01.23 | Bayer Equal-weight | Morgan Stanley | |
| 27.10.21 | Merck Equal-weight | Morgan Stanley | |
| 06.07.21 | Merck Equal-weight | Morgan Stanley | |
| 12.05.21 | Merck Equal-Weight | Morgan Stanley | |
| 06.05.21 | MorphoSys Equal-Weight | Morgan Stanley | |
| 25.11.20 | MorphoSys Equal-Weight | Morgan Stanley | |
| 21.10.20 | Merck Equal-Weight | Morgan Stanley | |